Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.07.2021 | Case report

Tozinameran

Anaphylaxis, syncope, dyspnoea and lack of efficacy: 4 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Modenese A, et al. Neutralizing anti-SARS-CoV-2 antibody titer and reported adverse effects, in a sample of italian nursing home personnel after two doses of the BNT162b2 vaccine administered four weeks apart. Vaccines 9: 652, No. 6, Jun 2021. Available from: URL: http://doi.org/10.3390/vaccines9060652 Modenese A, et al. Neutralizing anti-SARS-CoV-2 antibody titer and reported adverse effects, in a sample of italian nursing home personnel after two doses of the BNT162b2 vaccine administered four weeks apart. Vaccines 9: 652, No. 6, Jun 2021. Available from: URL: http://​doi.​org/​10.​3390/​vaccines9060652
Metadaten
Titel
Tozinameran
Anaphylaxis, syncope, dyspnoea and lack of efficacy: 4 case reports
Publikationsdatum
01.07.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-00052-x

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Antineoplastics

Case report

Enalapril

Case report

Multiple drugs

Case report

Secukinumab

Case report

Gefitinib